Vermilion Energy Inc. (TSE: VET - Get Free Report) (NYSE: VET) crossed above its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of C$13.07 and traded as high as C$19.83. Vermilion Energy shares last traded at C$19.48, with a volume of 1,040,380 shares changing hands. Analyst

CALGARY, AB, April 7, 2026 /PRNewswire/ - Vermilion Energy Inc. ("Vermilion", "We", "Our", or the "Company") (TSX: VET) (NYSE: VET) announces strong first quarter 2026 production, an asset acquisition and award of new land concessions in Germany, and the divestment of a non-producing asset in Croatia. Operations Update Q1 2026 production averaged approximately 125,000 boe/d, exceeding the top end of our quarterly guidance range of 122,000 to 124,000 boe/d.

VET gains momentum as premium-priced European gas exposure, rising production, and planned cost cuts support earnings and cash flow through 2026.

Vermilion Energy Inc. (NYSE: VET - Get Free Report) (TSE: VET)'s stock price gapped up prior to trading on Thursday. The stock had previously closed at $12.89, but opened at $13.54. Vermilion Energy shares last traded at $13.4560, with a volume of 279,592 shares changing hands. Wall Street Analyst Weigh In Several research firms have recently

Investors looking to capitalize on this strong oil environment may consider adding CHRD, DTI, MGY and VET to their portfolios.

AGRO, VET and VIST stand out on broker upgrades as markets witness massive selling, signaling potential upside despite geopolitical tensions and shifting sentiment.

Vermilion Energy (VET) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Does Vermilion Energy (VET) have what it takes to be a top stock pick for momentum investors? Let's find out.

MU, CRDO and VET emerge as momentum picks as Iran war uncertainty rattles markets, with strong yearly gains despite sharp recent pullbacks.

The Zacks Oil and Gas - International E&P industry spotlights HBRIY, VET and KOS as strong prices, cost discipline and portfolio shifts drive big 2026 EPS growth.